Amgen (AMGN) Tops Q1 EPS by 15c, Offers Guidance
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $385.65 +1.55%
Revenue Growth %: +5.1%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.1%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $4.25, $0.15 better than the analyst estimate of $4.10. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.63. Amgen sees FY2022 revenue of $25.4-26.5 billion, versus the consensus of $26.14 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Redburn upgrades Southwest, stays bullish on Delta and United
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
